Sfoglia per AUTORE
WILLMOTT L
Collezione ASL Biella
Items : 1
Time to quality of life (QoL) improvement or deterioration in patients (pts) with primary advanced or recurrent endometrial cancer (pA/R EC) treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial in Journal of Clinical Oncology
2025
ASL Biella
ASL Biella
Heitz F; Willmott L; Mathiesen HF; Gilbert L; Mendivil A; Zavallone L; Stuckey A; Novák Z; Diaz JP; Thijs A; Teneriello M; Edelson M; Holloway RW; Armstrong AJ; Buttin B; Powell MA; Westermayer B; Shen Q; Mirza MR; Ring K;